VACCINE FOR PREVENTION

Brand Owner (click to sort) Address Description
AVA-BRON INTERVET INC. 2 Giralda Farms Madison NJ 07940 VACCINE FOR THE PREVENTION OF NEW CASTLE DISEASE AND BRONCHITIS IN POULTRY;
AVA-BRON H SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 556 Morris Avenue Summit NJ 07901 VACCINE FOR THE PREVENTION OF NEW CASTLE DISEASE AND BRONCHITIS IN POULTRY;MAY 2, 1969, AS TO THE TRADEMARK AVA-BRON.;MAY 2, 1969, AS TO THE TRADEMARK AVA-BRON.;
AVA-POX INTERVET INC. 2 Giralda Farms Madison NJ 07940 VACCINE FOR THE PREVENTION OF POX IN FOWLS AND TURKEYS;HAVE-POX;
BLUCINE CUTTER LABORATORIES, INC. Berkeley CA VACCINE FOR THE PREVENTION OF BLUE TONGUE DISEASE IN SHEEP;BLUECINE;
BOVIMUNE Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 Vaccine for the Prevention of Colibacillosis in Cattle;
M-NINEVAX INTERVET INC. 2 Giralda Farms Madison NJ 07940 VACCINE FOR THE PREVENTION OF FOWL CHOLERA;M-9 VACCINE;
PORCIMUNE PITMAN-MOORE, INC. ONE CONWAY PARK 100 N. FIELD DRIVE LAKE FOREST IL 60045 Vaccine for the Prevention of Colibacillosis in Swine;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a method for producing a vaccine against cancerous disease, and the vaccine itself. This method involves first using one or more antibodies that are specifically effective against one or more antigens specially expressed by the tumor cells to select one or more mimotopes of said antigens from a phage peptide library. To obtain the vaccine, said mimotopes are conjugated to a macromolecular carrier singly or multiply in the form of their mono-, di-, tri- or oligomers. When administered, the inventively produced vaccine leads to a humoral immune response and thus to the formation of an active immunity as a consequence of vaccination.